TY - JOUR AU - Pape, Magdalena AU - Färber, Tanja AU - Seiferth, Caroline AU - Roth, Tanja AU - Schroeder, Stefanie AU - Wolstein, Joerg AU - Herpertz, Stephan AU - Steins-Loeber, Sabine PY - 2022 DA - 2022/10/27 TI -一个定制的性别敏感移动健康减肥干预(I-GENDO):开发和过程评估JO - JMIR Form Res SP - e38480 VL - 6 IS - 10 KW -移动健康KW -移动健康KW -电子健康KW -裁剪KW -性别KW -减肥干预KW -手机AB -背景:鉴于全球超重和肥胖的流行率的增加，数字减肥干预的数量也有所上升。然而，这些干预措施往往缺乏长期有效性的理论背景和数据。考虑体重相关心理参数的个体和性别差异可能会提高基于移动的减肥干预的有效性和可持续性。目的:本文介绍了结合基于计算机和自我剪裁功能的12周性别敏感的移动健康(mHealth)减肥干预(I-GENDO)的介绍和过程评估。方法:在2020年8月至2021年8月期间，德国的一项多中心研究I- gendo项目招募了超重(BMI 25.0-29.9 kg/m²)、I级肥胖(BMI 30.0-34.9 kg/m²)和II级肥胖(BMI 35.0-39.9 kg/m²)的受试者。移动健康干预旨在利用基于计算机的裁剪，针对与超重和肥胖的发展和持续有关的个人心理因素(例如，情绪化进食)。此外，干预措施采取了对性别敏感的方法，实现了针对性别的模块版本的自我定制。在考虑性别的同时，评估了主要模块的计算机分配、针对性别的模块版本的自我选择和使用模式。此外，还分析了可用性评估中的性别差异。 Results: Data from the intervention arm of the study were processed. A total of 116 individuals with overweight and obesity (77/116, 66.4% women; age mean 47.28, SD 11.66 years; BMI mean 33.58, SD 3.79 kg/m2) were included in the analyses. Overall, the compliance (90/109, 82.6%) and satisfaction with the app (mean 86% approval) were high and comparable with those of other mobile weight loss interventions. The usability of the intervention was rated with 71% (5.0/7.0 points) satisfaction. More women obtained the main module that focused on emotion regulation skills. Most men and women selected women-targeted versions of the main modules. Women used the app more frequently and longer than men. However, women and men did not differ in the progress of use patterns throughout the intervention. Conclusions: We developed a tailored gender-sensitive mHealth weight loss intervention. The usability of and engagement with the intervention were satisfactory, and the overall satisfaction with the intervention was also high. Gender differences must be considered in the evaluation of the effectiveness and sustainability of the intervention. SN - 2561-326X UR - https://formative.www.mybigtv.com/2022/10/e38480 UR - https://doi.org/10.2196/38480 UR - http://www.ncbi.nlm.nih.gov/pubmed/36301614 DO - 10.2196/38480 ID - info:doi/10.2196/38480 ER -